Variables | HR | 95% CI of HR | P valuea |
---|---|---|---|
Seven-lncRNA risk score (N = 541) | 2.14 | 1.783–2.568 | < 0.001 |
 Age | 1.008 | 0.995–1.021 | 0.223 |
 Gender | 1.391 | 1.013–1.91 | 0.041 |
 Adjuvant chemotherapy | 1.522 | 1.091–2.124 | 0.013 |
Seven-lncRNA risk score (N = 536) | 2.345 | 1.967–2.797 | < 0.001 |
 Age | 0.996 | 0.984–1.008 | 0.469 |
 Gender | 1.35 | 0.99–1.842 | 0.058 |
 KRAS mutation | 0.691 | 0.509–0.938 | 0.018 |
Seven-lncRNA risk score (N = 511) | 2.195 | 1.853–2.6 | < 0.001 |
 Age | 0.999 | 0.987–1.012 | 0.911 |
 Gender | 1.184 | 0.869–1.613 | 0.285 |
 MMR status | 2.617 | 1.378–4.97 | 0.003 |